Crossmark

In vivo and in silico study of europinidin against streptozotocin-isoproterenol-induced myocardial damage via alteration of hs-CRP/CPK-MB/Caspase-3/Bcl-2 pathways

Crossref DOI link: https://doi.org/10.1038/s41598-024-83900-8

Published Online: 2025-01-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alharbi, Khalid Saad

Afzal, Muhammad

Al-Abbasi, Fahad A.

Moglad, Ehssan

Al-Qahtani, Salwa D.

Almalki, Naif A. R.

Imam, Faisal

Sayyed, Nadeem

Kazmi, Imran
Funding

Funding for this research was provided by:

King Saud University, Riyadh, Saudi Arabia (RSPD2024R939)
License Information

Text and Data Mining valid from 2025-01-24

Version of Record valid from 2025-01-24
More Information

Article History

Received: 2 April 2024

Accepted: 18 December 2024

First Online: 24 January 2025

Declarations

:

: The authors declare no competing interests.

: The animal experiments were approved by the Institutional Ethical Committee of Animals, Trans-Genica Ethical Committee, M.S., India (TRS/PT/23/39/IAEC). In addition, all procedures for animal experiments described in this study were performed in accordance with the IAEC guidelines for the care and use of laboratory animals and ARRIVE guidelines.

Document is current

Any future updates will be listed below